Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for quality of life in acute heart failure
IRCT20250421065417N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- May 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Acute Heart Failure (AHF) and heart failure (HF) comparing Colchicine with Placebo (2 arms). Primary endpoint: Quality of life. Started May 2025; status: completed.
02
Drugs
colchicine
03
Conditions
Acute Heart Failure (AHF)heart failure (HF)
Beyond the preview
Go deeper on IRCT20250421065417N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250421065417N1.